Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-14

FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Umedica Laboratories USA Inc.)

View source ↗

Summary

The FDA granted supplemental approval for rosuvastatin calcium under an ANDA for Umedica Laboratories USA Inc., confirming the generic product's approval status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

SUPPL AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)